Mostrar el registro sencillo del ítem
dc.contributor.author
Cederquist, Carly T.
dc.contributor.author
Lentucci, Claudia
dc.contributor.author
Martinez Calejman, Camila

dc.contributor.author
Hayashi, Vanessa
dc.contributor.author
Orofino, Joseph
dc.contributor.author
Guertin, David
dc.contributor.author
Fried, Susan K.
dc.contributor.author
Jeong Lee, Mi
dc.contributor.author
Cardamone, M. Dafne
dc.contributor.author
Perissi, Valentina
dc.date.available
2022-10-21T18:31:11Z
dc.date.issued
2017-01
dc.identifier.citation
Cederquist, Carly T.; Lentucci, Claudia; Martinez Calejman, Camila; Hayashi, Vanessa; Orofino, Joseph; et al.; Systemic insulin sensitivity is regulated by GPS2 inhibition of AKT ubiquitination and activation in adipose tissue; Elsevier; Molecular Metabolism; 6; 1; 1-2017; 125-137
dc.identifier.issn
2212-8778
dc.identifier.uri
http://hdl.handle.net/11336/174419
dc.description.abstract
Objective Insulin signaling plays a unique role in the regulation of energy homeostasis and the impairment of insulin action is associated with altered lipid metabolism, obesity, and Type 2 Diabetes. The main aim of this study was to provide further insight into the regulatory mechanisms governing the insulin signaling pathway by investigating the role of non-proteolytic ubiquitination in insulin-mediated activation of AKT. Methods The molecular mechanism of AKT regulation through ubiquitination is first dissected in vitro in 3T3-L1 preadipocytes and then validated in vivo using mice with adipo-specific deletion of GPS2, an endogenous inhibitor of Ubc13 activity (GPS2-AKO mice). Results Our results indicate that K63 ubiquitination is a critical component of AKT activation in the insulin signaling pathway and that counter-regulation of this step is provided by GPS2 preventing AKT ubiquitination through inhibition of Ubc13 enzymatic activity. Removal of this negative checkpoint, through GPS2 downregulation or genetic deletion, results in sustained activation of insulin signaling both in vitro and in vivo. As a result, the balance between lipid accumulation and utilization is shifted toward storage in the adipose tissue and GPS2-AKO mice become obese under normal laboratory chow diet. However, the adipose tissue of GPS2-AKO mice is not inflamed, the levels of circulating adiponectin are elevated, and systemic insulin sensitivity is overall improved. Conclusions Our findings characterize a novel layer of regulation of the insulin signaling pathway based on non-proteolytic ubiquitination of AKT and define GPS2 as a previously unrecognized component of the insulin signaling cascade. In accordance with this role, we have shown that GPS2 presence in adipocytes modulates systemic metabolism by restricting the activation of insulin signaling during the fasted state, whereas in absence of GPS2, the adipose tissue is more efficient at lipid storage, and obesity becomes uncoupled from inflammation and insulin resistance.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier

dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.subject
ADIPOSE TISSUE
dc.subject
AKT
dc.subject
GPS2
dc.subject
INSULIN
dc.subject
OBESITY
dc.subject
UBIQUITIN
dc.subject.classification
Bioquímica y Biología Molecular

dc.subject.classification
Medicina Básica

dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD

dc.title
Systemic insulin sensitivity is regulated by GPS2 inhibition of AKT ubiquitination and activation in adipose tissue
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2022-06-21T19:21:47Z
dc.journal.volume
6
dc.journal.number
1
dc.journal.pagination
125-137
dc.journal.pais
Estados Unidos

dc.journal.ciudad
New York
dc.description.fil
Fil: Cederquist, Carly T.. University Of Boston. School Of Medicine.; Estados Unidos
dc.description.fil
Fil: Lentucci, Claudia. University Of Boston. School Of Medicine.; Estados Unidos
dc.description.fil
Fil: Martinez Calejman, Camila. University Of Massachussets. Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Hayashi, Vanessa. University Of Boston. School Of Medicine.; Estados Unidos
dc.description.fil
Fil: Orofino, Joseph. University Of Boston. School Of Medicine.; Estados Unidos
dc.description.fil
Fil: Guertin, David. University Of Massachussets. Medical School; Estados Unidos
dc.description.fil
Fil: Fried, Susan K.. Icahn School of Medicine at Mount Sinai; Estados Unidos
dc.description.fil
Fil: Jeong Lee, Mi. University of Boston. School of Medicine; Estados Unidos
dc.description.fil
Fil: Cardamone, M. Dafne. University of Boston. School of Medicine; Estados Unidos
dc.description.fil
Fil: Perissi, Valentina. University Of Boston. School Of Medicine.; Estados Unidos
dc.journal.title
Molecular Metabolism
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.molmet.2016.10.007
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2212877816302101
Archivos asociados